← FDA Drug Approvals (Drugs@FDA)

EMLA

NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 1998-02-04

Drug application

FDA Application #

NDA020962

Application type

New Drug Application

Brand name

EMLA

Generic name

Lidocaine

Active ingredients

LIDOCAINE; PRILOCAINE

Dosage form

DISC

Route

TOPICAL

Marketing status

Discontinued

Sponsor

ASTRAZENECA

First approval

1998-02-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown